These observations suggest that ectopic overexpression of CD133 leads to osteosclerotic and osteolytic activation of bone adjacent to the tumor, particularly in bone injected with PC3 cells, and that CD133 expression is associated with metastasis of PC to bone. This evidence concerns the gene PROM1 and neoplasm.